skip to main content
back

Press Releases

10 Nov 2003

Remodulin Long-Term Data Presented At American Heart Association Conference
Download pdf

06 Nov 2003

United Therapeutics Reports Third Quarter 2003 Financial Results
Download pdf

30 Oct 2003

United Therapeutics To Announce Third Quarter Financial Results Before Market Open On November 6, 2003
Download pdf

07 Oct 2003

Stuart Rich, M.D. Joins United Therapeutics as Chief Medical Officer
Download pdf

02 Oct 2003

Remodulin Long-Term Data Presented at European Respiratory Society Conference
Download pdf

22 Sep 2003

European Approval of Remodulin Delayed
Download pdf

08 Sep 2003

United Therapeutics Engages Ernst & Young As Independent Public Accountants
Download pdf

21 Aug 2003

FDA Extends Timeline For Completion of Remodulin Pase IV Study
Download pdf

05 Aug 2003

United Therapeutics Reports Second Quarter 2003 Financial Results
Download pdf

29 Jul 2003

United Therapeutics to Announce Second Quarter Financial Results Before Market Open On August 5, 2003
Download pdf

14 Jun 2003

United Therapeutics Files for IND for Intravenous Remodulin For the Treatment of Pulmonary Arterial Hypertension
Download pdf

02 Jun 2003

OVAREX® Study Demonstrates Clinical Benefits for Ovarian Cancer Patients
Download pdf

(Showing 445 – 456 of 513)